Wealthspire Advisors, L.P. - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.

Quarter-by-quarter ownership
Wealthspire Advisors, L.P. ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$306,000
-32.0%
20,040
+0.2%
0.03%
-33.3%
Q1 2018$450,000
+22400.0%
20,007
+29761.2%
0.04%
Q4 2017$2,0000.0%67
+59.5%
0.00%
Q3 2017$2,00042
+600.0%
0.00%
Q2 2017$0
-100.0%
6
-87.5%
0.00%
Q1 2017$2,00048
+860.0%
0.00%
Q4 2016$05
-44.4%
0.00%
Q3 2016$09
+80.0%
0.00%
Q2 2016$0
-100.0%
5
-89.1%
0.00%
Q4 2015$2,000460.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Baker Brothers Advisors 28,439,114$590,396,0003.89%
GREAT POINT PARTNERS LLC 1,196,098$24,831,0003.87%
EMORY UNIVERSITY 196,601$4,081,0002.67%
Ghost Tree Capital, LLC 500,000$10,380,0002.21%
Ghost Tree Capital, LLC 500,000$10,380,0002.21%
NEXTHERA CAPITAL LP 500,000$10,380,0001.99%
Palo Alto Investors LP 1,684,180$34,964,0001.41%
Opus Point Partners Management, LLC 20,828$432,0001.03%
Opaleye Management Inc. 195,000$4,048,0001.03%
GARRISON BRADFORD & ASSOCIATES INC 48,500$1,007,0000.81%
View complete list of ACADIA PHARMACEUTICALS INC shareholders